BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17651480)

  • 1. Favorable prognostic value of SOCS2 and IGF-I in breast cancer.
    Haffner MC; Petridou B; Peyrat JP; Révillion F; Müller-Holzner E; Daxenbichler G; Marth C; Doppler W
    BMC Cancer; 2007 Jul; 7():136. PubMed ID: 17651480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcome associated with an IGF-1 ligand signature in breast cancer.
    Mu L; Tuck D; Katsaros D; Lu L; Schulz V; Perincheri S; Menato G; Scarampi L; Harris L; Yu H
    Breast Cancer Res Treat; 2012 May; 133(1):321-31. PubMed ID: 22297468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
    Chong KY; Subramanian A; Mokbel K; Sharma AK
    J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low cdc27 and high securin expression predict short survival for breast cancer patients.
    Talvinen K; Karra H; Pitkänen R; Ahonen I; Nykänen M; Lintunen M; Söderström M; Kuopio T; Kronqvist P
    APMIS; 2013 Oct; 121(10):945-53. PubMed ID: 23755904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
    Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
    Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
    Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
    PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
    Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
    Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
    Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
    Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
    Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
    Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.
    Collie-Duguid ES; Sweeney K; Stewart KN; Miller ID; Smyth E; Heys SD
    Breast Cancer Res Treat; 2012 Apr; 132(3):807-18. PubMed ID: 21695460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
    Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
    Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
    Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
    BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.
    Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Kawaguchi M; Miura Y; Iwase H
    Clin Cancer Res; 2005 Jan; 11(1):193-8. PubMed ID: 15671546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
    Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression.
    Fu P; Ibusuki M; Yamamoto Y; Hayashi M; Murakami K; Zheng S; Iwase H
    Breast Cancer Res Treat; 2011 Nov; 130(1):307-17. PubMed ID: 21748295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT; Xie J; Torhorst J; Bubendorf L; Haas P; Kononen J; Sauter G; Rui H
    J Clin Oncol; 2004 Jun; 22(11):2053-60. PubMed ID: 15169792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.